Allergan Aesthetics
BOTOX® Cosmetic
injectable neuromodulator (botulinum toxin type A)
BOTOX Cosmetic is made by Allergan Aesthetics, part of AbbVie. Its active ingredient, onabotulinumtoxinA, is a purified protein made from the bacterium Clostridium botulinum; the same formulation was first FDA approved in 1989, under the name BOTOX, to treat two eye-muscle conditions (strabismus and blepharospasm). When a small amount is injected into a muscle, it blocks the nerve signals that tell that muscle to contract, which temporarily reduces the muscle's activity. The FDA approved the cosmetic version, BOTOX Cosmetic, in 2002 for temporary improvement of moderate to severe glabellar lines (the frown lines between the eyebrows), and later expanded that approval to crow's feet lines, forehead lines, and, most recently, platysma bands (vertical neck bands). It has been FDA approved for cosmetic use since 2002, longer than the other two neurotoxins the clinic carries.
The record
- BOTOX (onabotulinumtoxinA) was first FDA approved in 1989, for strabismus and blepharospasm.
- BOTOX Cosmetic was FDA approved on April 15, 2002, for temporary improvement of moderate to severe glabellar lines.
- FDA approved BOTOX Cosmetic for lateral canthal lines (crow's feet) on September 11, 2013.
- FDA approved BOTOX Cosmetic for forehead lines associated with frontalis muscle activity on October 3, 2017.
- AbbVie completed its acquisition of Allergan, BOTOX's maker, on May 8, 2020.
- FDA approved BOTOX Cosmetic for platysma bands (vertical jaw-to-neck bands) on October 18, 2024.
Where this came from
- BOTOX Cosmetic (onabotulinumtoxinA) Celebrates 20 Years Since First U.S. FDA Approval (AbbVie, Apr 13, 2022)
- ADDING MULTIMEDIA: FDA Approves BOTOX Cosmetic (onabotulinumtoxinA) for Temporary Improvement of Moderate to Severe Lateral Canthal Lines (Crow's Feet Lines) in Adults (Business Wire, Sep 11, 2013)
- FDA Approves BOTOX Cosmetic (OnabotulinumtoxinA) for the Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines (PR Newswire, Oct 3, 2017)
- AbbVie Completes Transformative Acquisition of Allergan (AbbVie, May 8, 2020)
- BOTOX Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands) (AbbVie, Oct 18, 2024)
- FDA approves Botox Cosmetic for platysma bands (Healio, Oct 21, 2024)
Also in injectables
BOTOX® Cosmetic and its logo belong to Allergan Aesthetics, an AbbVie company (AbbVie completed its acquisition of Allergan on May 8, 2020). This page describes equipment and products used at UDERMA Medspa & Laser; it is general information, not medical advice, and whether this one suits you is a conversation to have at a consultation.
Want to know if this is right for you?
UDERMA Medspa & Laser · 36426 US Hwy 19 N, Palm Harbor, FL · 727-569-6616
Book a consultation